Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

IDO Pathway Analysis for Identifying Novel Biomarkers in Multiple Myeloma

Vladimir Petrovic, PhD, Jamie Wong, Cedric E. Dos Santos, PhD, Richard Smith, Dan Fitzpatrick, Robert Loberg, Ariel Avilion, PhD

Blood (2018) 132 (Supplement 1): 5572.

https://doi.org/10.1182/blood-2018-99-111392

Published: 2018

Journal Articles

Utilization of Metabolomics to Identify Biomarkers in Hematological Malignancies: Role of IDO and the Tryptophan Pathway

Elizabeth Finger, Jamie Wong, Julia Gray, Dan Rock, Robert Loberg, Dan Fitzpatrick, Richard Smith, Xiaozhen Wang, Cedric E. Dos Santos

Blood (2017) 130 (Supplement 1): 5100.

https://doi.org/10.1182/blood.V130.Suppl_1.5100.5100

Published: 2017

Journal Articles

Peripheral Blood As a Substitute for Bone Marrow for Assessing the Immune Profile in AML

Robin Lesley, PhD, Karl Beutner, Abraham A Anderson, Dan Fitzpatrick, Robert Loberg, Bhakti Mehta, Cedric E. Dos Santos

Blood (2017) 130 (Supplement 1): 3924.

https://doi.org/10.1182/blood.V130.Suppl_1.3924.3924

Published: 2017

Journal Articles

Epor Is Not Expressed or Functional in Primary Tumor Cells Isolated Directly From Human Primary and Metastatic Epithelial Tumors Including Breast, Non-Small Cell Lung, Colorectal, and Ovarian Tissues

Ian McCaffery, PhD, John M Rossi, Katherine L Paweletz, Yanyan Tudor, Steve Elliott, V Dan Fitzpatrick, PhD, C. Glenn Begley, PhD, MBBS, FRACP, FRCPA, Scott D Patterson, PhD

Blood (2011) 118 (21): 4781.

https://doi.org/10.1182/blood.V118.21.4781.4781

Published: 2011

Journal Articles

Analysis of Cell Surface Erythropoietin Receptor (EpoR) Expression and Function in Epithelial Human Tumor Tissues Reveals No Detectable Cell Surface Expression or Function

Ian McCaffery, John Rossi, Katherine Paweletz, Yanyan Tudor, Steve Elliott, Leigh Busse, V. Dan Fitzpatrick, Scott D. Patterson

Blood (2008) 112 (11): 5396.

https://doi.org/10.1182/blood.V112.11.5396.5396

Published: 2008

NARROW

IDO Pathway Analysis for Identifying Novel Biomarkers in Multiple Myeloma

Utilization of Metabolomics to Identify Biomarkers in Hematological Malignancies: Role of IDO and the Tryptophan Pathway

Peripheral Blood As a Substitute for Bone Marrow for Assessing the Immune Profile in AML

Epor Is Not Expressed or Functional in Primary Tumor Cells Isolated Directly From Human Primary and Metastatic Epithelial Tumors Including Breast, Non-Small Cell Lung, Colorectal, and Ovarian Tissues

Analysis of Cell Surface Erythropoietin Receptor (EpoR) Expression and Function in Epithelial Human Tumor Tissues Reveals No Detectable Cell Surface Expression or Function

Email alerts

ASH Publications

American Society of Hematology

IDO Pathway Analysis for Identifying Novel Biomarkers in Multiple Myeloma

Utilization of Metabolomics to Identify Biomarkers in Hematological Malignancies: Role of IDO and the Tryptophan Pathway

Peripheral Blood As a Substitute for Bone Marrow for Assessing the Immune Profile in AML

Epor Is Not Expressed or Functional in Primary Tumor Cells Isolated Directly From Human Primary and Metastatic Epithelial Tumors Including Breast, Non-Small Cell Lung, Colorectal, and Ovarian Tissues

Analysis of Cell Surface Erythropoietin Receptor (EpoR) Expression and Function in Epithelial Human Tumor Tissues Reveals No Detectable Cell Surface Expression or Function

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only